Flutamide, tablets 250 mg 84 pcs
€50.63 €42.19
Out of stock
(E-mail when Stock is available)
Flutamide is a nonsteroidal drug with anti-androgenic, anti-tumor effects.
Pharmacodynamics
Competitively blocks androgen receptors of target tissue cells and prevents androgens binding to them. Prevents the manifestation of the biological effects of androgens in androgen-sensitive organs (including the prostate gland and seminal vesicles). After flutamide administration, an increase in plasma levels of testosterone and estradiol has been observed. Flutamide’s ability to inhibit the action of testosterone at the cellular level is in addition to the drug-induced castration caused by gonadotropin-releasing hormone (GnRH) analogues.
Pharmacokinetics
When taken orally, it is rapidly and completely absorbed from the GI tract. It is metabolized in the liver. At least 6 metabolites are identified. The main metabolite found in blood plasma – alpha-hydroxylated derivative (2-oxiflutamide) – is biologically active. Binding to plasma proteins is 94-96% (flutamide) and 92-94% (2-oxiflutamide). Cmax of 2-oxiflutamide is 2 h. T1/2 2-oxiflutamide is 6 h (in elderly patients, 8 h after a single dose and 9.6 h when stable concentration is reached). It is excreted mainly by the kidneys as metabolites, 4.2% – with the feces within 72 hours.
Indications
Active ingredient
Composition
1 tablet contains:
Active ingredients:
Flutamide 250 mg.
How to take, the dosage
Flutamide is prescribed 1 tablet 3 times a day every 8 hours. If a positive effect is achieved, the drug is used until signs of tumor disease progression appear.
In case of combined therapy with LHRH agonists, both drugs may be given simultaneously or flutamide may be started three days before the first LHRH agonist.
Interaction
It is believed that there may be a drug interaction when flutamide is used simultaneously with paracetamol, opioid analgesics, NSAIDs.
Special Instructions
In the treatment of prostate cancer it is necessary to monitor the liver function (laboratory tests should be performed once a month for the first four months and then regularly).
In case of increase in the level of liver enzymes by 2-3 times in comparison with the upper limit of normal values and/or appearance of jaundice in the absence of liver metastases, flutamide should be discontinued. If the first symptoms of liver dysfunction occur, such as itching of the skin, darkened urine, nausea, vomiting, persistent loss of appetite, yellowing of the skin or whites of the eyes, pain in the right subcostal area or flu-like symptoms of unclear origin should be immediately consulted with a physician.
When evaluating the differential diagnosis of male hypogonadism, the following indicators should be considered: in healthy individuals with normal basal gonadotropin excretion after administration of the drug there is an increase in their excretion by 1.5 times or more; in primary hypogonadism the initial gonadotropin excretion is significantly increased, less often normal, the drug administration leads to a further increase in their excretion by 1.5-2 times or more; in secondary hypogonadism the initial gonadotropin excretion is reduced, less often normal, no significant increase in their excretion after the drug administration is observed.
Contraindications
Hypersensitivity, severe liver, kidney, thyroid diseases.
With caution: patients with reduced liver function, patients with a tendency to thrombosis and with cardiovascular disease.
Side effects
Endocrine system disorders: gynecomastia and/or galactorrhea.
Digestive system disorders: nausea, vomiting, jaundice, diarrhea, increased liver transaminase activity.
Water-electrolyte metabolism: fluid retention.
Other: rarely – headache, thromboembolism, renal dysfunction, sleep disorders, subcutaneous hemorrhage, lupus-like syndrome.
Overdose
Treatment: if the patient is conscious and without spontaneous vomiting, vomiting should be induced.
Vital function control and symptomatic therapy are necessary.
Hemodialysis and peritoneal dialysis are ineffective (due to high plasma protein binding).
Pregnancy use
It does not apply.
Weight | 0.088 kg |
---|---|
Shelf life | 3 years. |
Conditions of storage | Store in a dry, light-protected place at 15-30 °C. |
Manufacturer | Orion Corporation, Finland |
Medication form | pills |
Brand | Orion Corporation |
Related products
Buy Flutamide, tablets 250 mg 84 pcs with delivery to USA, UK, Europe and over 120 other countries.